21 May 2013
Keywords: actelion, recovers, poor, first, quarter, swiss, biotechnology
Article | 04 August 2008
Swiss biotechnology firm Actelion reported improved results for the first six months of 2008 on the recovery of its lead product, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.